News Archive

Leadership Maryland graduated 50 members of the Class of 2018 who completed the professional development program during its 26th annual graduation ceremony Dec. 4 at the Lord Baltimore Hotel.

TEDCO will fund and support five Maryland startups as part of its Pre-Seed Builder Fund

TEDCO announces its recent round of startups receiving funding and mentorship through the organization’s Pre-Seed Builder Fund

The company created a platform transcribes podcast episodes 24 hours a day. Now it's looking to provide "social listening."

Potomac, Maryland-based pre-sale home improvement company Curbio Inc., which recently raised $4 million in new funding, is using the investment to expand outside of the Washington region.

Ask small business entrepreneurs what they’re thankful for this year and they’ll probably have two answers: funding and people.

IBBR researchers recently received $3.9 million from the National Institutes of Health (NIH) to develop a multi-specific, single agent antibody therapeutic against HIV-1 to block virus infection and to clear the reservoir of HIV-infected cells from the body.

The startup offering streaming health and fitness classes is expanding in corporate wellness. Former IKEA North America President Pernille Spiers-Lopez and Boulder Ventures' Josh Fidler joined the board.

Amazon’s move to Arlington will drive a demand for talent and help bring more venture capital into a region that has been slowly improving in that area.

How storytelling plays a part in the Baltimore startup community

This program will “offer operational guidance and financial support to Maryland startups founded by socially or economically disadvantaged entrepreneurs.”

RackTop Systems, a leading provider of high-performance Software-Defined Storage embedded with advanced security, encryption and compliance, and Network Runners, a top technology consulting services company that serves the commercial and federal government market spaces, today announced they will be

MII portfolio company Asclepix Therapeutics raised over $5 million in new funding that will assist in development of new treatment for eye diseases that are leading causes of blindness in adults.

Baltimore biopharmaceutical company AsclepiX Therapeutics Inc. is developing therapies to target eye diseases.

SERAXIS Inc., a rapidly growing regenerative medicine company today announced the publication of important trial considerations for SR-01, its pluripotent stem cell-derived islet therapy for insulin-dependent diabetes.